5 active warrant series; nearest expiry 2026-11-12.
Compare this book against every issuer →5 option grants covering 11,422,261 shares (~7.2% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $1.66 | Nov 12, 2026 46d | 10K | OTM | 0.0% | C$17K | Auto |
| option | $1.13 | Feb 8, 2027 134d | 178K | OTM | 0.1% | C$201K | Auto |
| option | $0.57 | Oct 3, 2027 371d | 52K | OTM | 0.0% | C$30K | Auto |
| option | $0.10 | Oct 17, 2029 1116d | 6.3M | ITM | 3.9% | C$628K | Auto |
| option | $0.23 | Jan 13, 2031 1569d | 4.9M | OTM | 3.1% | C$1.1M | Auto |
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
159,583,833 shares outstanding, plus 0 from warrants and 11,422,261 from options — a fully diluted 171,006,094 shares, or ~7.2% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
5 active warrant series; nearest expiry 2026-11-12.
Compare this book against every issuer →5 option grants covering 11,422,261 shares (~7.2% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $1.66 | Nov 12, 2026 46d | 10K | OTM | 0.0% | C$17K | Auto |
| option | $1.13 | Feb 8, 2027 134d | 178K | OTM | 0.1% | C$201K | Auto |
| option | $0.57 | Oct 3, 2027 371d | 52K | OTM | 0.0% | C$30K | Auto |
| option | $0.10 | Oct 17, 2029 1116d | 6.3M | ITM | 3.9% | C$628K | Auto |
| option | $0.23 | Jan 13, 2031 1569d | 4.9M | OTM | 3.1% | C$1.1M | Auto |
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
159,583,833 shares outstanding, plus 0 from warrants and 11,422,261 from options — a fully diluted 171,006,094 shares, or ~7.2% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
